Team:Queens

From 2009.igem.org

(Difference between revisions)

Revision as of 04:30, 1 August 2009

Team Background

More information yet to come!

Project Background

This year, the Queen’s iGEM team is exploring a new synthetic biology approach to treat atherosclerosis. The purpose of our project is to engineer E.coli cells to target and deliver drugs to the site of atherosclerotic plaque. This will be accomplished by designing a binding system that allows E.coli to adhere to plaque, an inducible effector system that produces and releases drugs to site of plaques, and a termination system that detaches the E.coli from the plaque and triggers self-destruction. For a more detailed explanation and breakdown please see our Project page.

Last Updated: May 26, 2009 by Fr₃P

@@ Line 54: / Line 54: @@
 <p style="font-size:175%;font-family:corbel;color:#172C4E;font-weight:bold"><i>Project Background</i></p>
 <p style="font-size:120%;font-family:palatino linotype;color:#ECB528">
-We have chosen our main project of interest. We are now in the final stages of determining the feasibility of this project and finding potential solutions for all the snags we have encountered. In the event that any of the snags become show-stoppers we have a backup project lined up. We should have a detailed project proposal nearing the end of this week and will be able to post more information. Cheers! Please check back for updates!
+This year, the Queen’s iGEM team is exploring a new synthetic biology approach to treat atherosclerosis. The purpose of our project is to engineer E.coli cells to target and deliver drugs to the site of atherosclerotic plaque. This will be accomplished by designing a binding system that allows E.coli to adhere to plaque, an inducible effector system that produces and releases drugs to site of plaques, and a termination system that detaches the E.coli from the plaque and triggers self-destruction. For a more detailed explanation and breakdown please see our Project page.
 </p>
 </td>